PuraMed BioScience Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
32.20
8.60
693.10
42.80
-
Cost of Goods Sold (COGS) incl. D&A
62.70
325.80
687.30
501.40
1,760.80
Gross Income
30.50
317.20
5.70
458.50
1,760.80
SG&A Expense
1,131.60
769.90
1,354.40
1,547.10
935.90
EBIT
1,301.80
1,087.10
1,348.70
2,005.60
2,696.80
Unusual Expense
-
11.90
103.20
28.20
1,457.90
Non Operating Income/Expense
-
-
0.30
-
-
Interest Expense
179.50
432.30
475.60
528.80
1,071.30
Pretax Income
1,481.00
1,507.50
1,721.40
2,562.60
5,225.90
Consolidated Net Income
1,481.00
1,507.50
1,721.40
2,562.60
5,225.90
Net Income
1,481.00
1,507.50
1,721.40
2,562.60
5,225.90
Net Income After Extraordinaries
1,481.00
1,507.50
1,721.40
2,562.60
5,225.90
Net Income Available to Common
1,481.00
1,507.50
1,721.40
2,562.60
5,225.90
EPS (Basic)
4.40
4.00
3.20
3.20
0.50
Basic Shares Outstanding
322.40
388.60
539.60
773.90
10,497.00
EPS (Diluted)
4.59
3.88
3.19
3.31
0.50
Diluted Shares Outstanding
322.40
388.60
539.60
773.90
10,497.00
EBITDA
1,253.10
1,038.50
1,297.20
1,950.80
2,643.70
Other Operating Expense
139.80
-
-
-
-
Non-Operating Interest Income
0.40
0.00
-
-
-
About PuraMed BioScience
View Profile
